AML Induction Chemotherapy Package

Medical Visa
Assistance

Tele-Video
Consultation

Language Interpretation
Services

Second Medical
Opinion

Post-Treatment
Care Coordination

Coordinating care at accredited hospitals, including

Apollo HospitalsFortis HealthcareManipal HospitalsSarvodaya Hospital

Not sure where to start? Get a free medical opinion

Not sure what your treatment will cost? Free, instant, itemised estimate -- treatment, visa, flights, hotel & food

What will your treatment cost?

Chat Assistance

AML Induction Chemotherapy Cost in India

Surgery Name	Cost	Room	Hospitalization
AML Induction Chemotherapy Package	USD 15000 - USD 20000	Twin Sharing	4 weeks

✓ Inclusion

✔Haemato-oncologist consultation and daily review during the stay
✔Standard 7+3 induction chemotherapy drugs (cytarabine with daunorubicin or idarubicin)
✔About 4 weeks of hospital stay in a twin-sharing room
✔Central line (PICC) insertion and care
✔Routine blood counts, kidney and liver tests during the stay
✔Standard blood and platelet transfusions as per package limit
✔Routine antibiotics, anti-nausea and supportive medicines
✔Nursing care with infection-control precautions
✔Hospital meals as per dietitian advice
✔Remission bone marrow test at the end of induction (as per hospital package)
✔Free: airport pick-up & drop, visa invitation letter, interpreter & coordinator (Satyug Healthcare)

✗ Exclusion

✖Diagnostic bone marrow, flow cytometry, cytogenetic and molecular tests
✖Targeted drugs such as midostaurin, gilteritinib, gemtuzumab or venetoclax
✖High-cost antifungals and antibiotics beyond the package
✖ICU stay or ventilator support
✖Single or HEPA-filtered private room upgrade
✖Extra transfusions and stay beyond 4 weeks
✖Consolidation chemotherapy and bone marrow transplant
✖Hotel stay, food and local travel for attendants
✖Air tickets and visa fees

Know More About Procedure & Surgery

🇮🇳 BLOOD CANCER PACKAGE — INDIA

AML Induction Chemotherapy in India

Intensive first-phase chemotherapy (such as the 7+3 regimen) for acute myeloid leukaemia, given by experienced haemato-oncologists in dedicated leukaemia units at accredited Indian hospitals – at a fraction of Western and Gulf costs.

✅ Free Medical Opinion in 48–72 h🩸 Dedicated Leukaemia & BMT Units💰 Starting USD 15,000✈️ Visa & Airport Support🗣️ Interpreter Available

💉

7 days

Chemotherapy course

🏥

4 weeks

Hospital stay

📈

60–80%

Remission (<60 yrs)

📅

5–6 weeks

Total stay in India

📖 What is AML Induction Chemotherapy?

Acute myeloid leukaemia (AML) is a fast-growing blood cancer that starts in the bone marrow, the soft tissue inside bones where blood is made. Abnormal young cells called blasts grow quickly and crowd out normal blood cells. This causes anaemia (low red cells), infections (low white cells) and bleeding (low platelets). Without treatment, AML can become life-threatening within weeks, so treatment should start quickly.

Induction chemotherapy is the first and most intensive phase of AML treatment. Its goal is to clear the blasts and bring the disease into complete remission (less than 5% blasts in the marrow and normal blood counts). The standard '7+3' regimen gives cytarabine for 7 days and daunorubicin or idarubicin for 3 days, sometimes with targeted drugs (such as midostaurin for FLT3-positive AML). Because blood counts fall very low for 2–3 weeks, patients stay in hospital in a protected ward. Induction is followed by consolidation chemotherapy and, for many patients, a bone marrow transplant.

🖼️ Understand It in Pictures

💡 In simple words

Acute myeloid leukaemia (AML) is a fast-growing cancer of the bone marrow that fills the blood with abnormal white cells. Induction chemotherapy is the first, intensive treatment, given in hospital, to clear the leukaemia cells so normal blood can grow back.

Normal blood vs AML

Induction Chemotherapy for AML: normal vs abnormal explained in pictures

👀 Symptoms in Pictures

Symptoms that may need Induction Chemotherapy for AML - in pictures

🩻 Scans & Tests — What Doctors See

**PET-CT scan picture**
Bright spots show areas where cancer cells are very active anywhere in the body.
Image: Eric Tse et al., CC BY 4.0, via Wikimedia Commons

🎬 The Treatment Journey in Pictures

Induction Chemotherapy for AML step by step in pictures

**Chemotherapy drip**
Cancer medicines are given slowly into a vein from bags like these.
Image: CC0, via Wikimedia Commons

📅 Recovery at a Glance

Recovery timeline after Induction Chemotherapy for AML

Drawings: Satyug Healthcare (simplified, not to scale). Photos: Wikimedia Commons; author and licence under each photo.

🩺 Who Needs This Treatment

🩸

Newly diagnosed AML

Adults and children fit for intensive chemotherapy.

🧬

AML with FLT3 mutation

7+3 combined with a targeted FLT3 inhibitor such as midostaurin.

🎯

Core-binding factor AML

Favourable-risk AML that may receive gemtuzumab ozogamicin with induction.

🔁

Secondary or therapy-related AML

AML after MDS or previous chemotherapy – may receive CPX-351 (liposomal daunorubicin-cytarabine).

👴

Older or less fit patients

Lower-intensity options such as azacitidine or decitabine with venetoclax.

🌱

Before bone marrow transplant

Remission must be reached before transplant can be planned.

⚠️ Symptoms of AML

➤Severe tiredness and weakness
➤Pale skin and breathlessness
➤Frequent or serious infections
➤Fever without clear cause

➤Easy bruising or bleeding gums
➤Small red spots on the skin
➤Bone or joint pain
➤Swollen gums or weight loss

💡 Not every AML patient receives intensive 7+3 induction. Acute promyelocytic leukaemia (APL), a special type, is treated with ATRA and arsenic trioxide instead. Older or frail patients may do better with lower-intensity therapy such as azacitidine plus venetoclax. The right plan depends on age, fitness and genetic tests of the leukaemia.

🔬 Tests Before Treatment

Test	Why it is done
Complete blood count & peripheral smear	Shows blasts and how low the normal blood cells are.
Bone marrow aspiration & biopsy	Confirms AML and measures the percentage of blasts.
Flow cytometry	Identifies the exact type of leukaemia cells.
Cytogenetics & molecular tests (FLT3, NPM1, CEBPA, etc.)	Decide the risk group and whether targeted drugs are needed.
Echocardiogram (2D echo)	Checks heart function before anthracycline drugs.
Kidney, liver tests & infection screening	Ensure the body can handle chemotherapy and detect hidden infections.
HLA typing (patient and siblings)	Prepares early for a possible bone marrow transplant.

🏥 The Procedure — Step by Step

AML Induction Chemotherapy procedure steps

Diagnosis review

The haemato-oncologist reviews your reports and confirms the AML type and plan.

Admission & baseline tests

Bone marrow test, genetic tests, echo and infection screening are done.

Central line placement

A PICC or central line is inserted for chemotherapy, transfusions and blood tests.

Chemotherapy days 1–7

Cytarabine runs as a continuous drip for 7 days; daunorubicin or idarubicin on days 1–3.

Targeted therapy (if needed)

FLT3 inhibitors or other drugs are added based on genetic results.

Low-count phase

Blood counts drop for 2–3 weeks; you stay in a protected room with infection precautions.

Supportive care

Blood and platelet transfusions, antibiotics, antifungals and nutrition support.

Day 14 bone marrow (if advised)

Checks whether the leukaemia is clearing.

Count recovery

White cells and platelets usually recover around day 21–28.

Remission assessment & discharge

Bone marrow test confirms remission; next phase (consolidation or transplant) is planned.

⚖️ Induction Treatment Options

Regimen	What is given	Best for
7+3 (cytarabine + daunorubicin/idarubicin)	7 days cytarabine, 3 days anthracycline	Fit adults with most types of AML
7+3 + midostaurin	Standard 7+3 with oral FLT3 inhibitor	FLT3-mutated AML
7+3 + gemtuzumab ozogamicin	Antibody-drug added to induction	Favourable-risk (CBF) AML
CPX-351 (liposomal daunorubicin-cytarabine)	Combined liposomal drug	Secondary or therapy-related AML in older fit adults
Azacitidine/decitabine + venetoclax	Lower-intensity tablets and injections	Older or unfit patients

📊 NCCN and ELN 2022 AML guidelines recommend intensive induction for fit patients; with 7+3, complete remission is reached in about 60–80% of adults under 60 and about 40–60% of fitter older adults, and adding midostaurin improved survival in FLT3-mutated AML in the RATIFY trial.

📅 Your Day-by-Day Plan in India

Day	What happens
Day 1	Arrival, airport pick-up and urgent haemato-oncology consultation
Day 1–3	Admission, bone marrow test, genetic tests, echo and central line
Day 3–10	Induction chemotherapy (7 days)
Day 10–25	Low-count phase in a protected ward with transfusions and infection care
Day 25–30	Blood counts recover; remission bone marrow test; discharge after about 4 weeks
Week 5–6	Stay near the hospital; plan consolidation or bone marrow transplant
Week 6	If continuing at home, final review and treatment plan – Fly home ✈️

🌱 Recovery After Treatment

🛡️

Week 1

Chemotherapy drip; nausea controlled with medicines.

🩸

Week 2–3

Lowest counts; fever is treated urgently with IV antibiotics; transfusions given.

💇

Week 2–4

Hair loss, mouth ulcers and tiredness are common and temporary.

📈

Week 3–4

Counts recover; appetite and energy slowly return.

🔬

Day 28–35

Remission bone marrow result guides the next step.

🌱

Next 3–6 months

Consolidation chemotherapy (usually 3–4 cycles) and/or bone marrow transplant.

🏆 Success Rate

Outcome	Result
Complete remission, adults under 60	About 60–80%
Complete remission, fit adults over 60	About 40–60%
Complete remission, children	About 85–90%
Treatment-related death during induction	About 3–10%, higher in older or sicker patients
5-year survival (all adults under 60)	About 35–50%, depending on genetic risk

Results depend mainly on the genetic risk group of the leukaemia, age, general fitness, infection control during low counts and whether consolidation or a bone marrow transplant follows remission.

🩹 Risks & Possible Complications

Induction chemotherapy is intensive. Most side effects are expected and managed by the team.

•Infection and fever during low counts (febrile neutropenia) – very common, over 80%
•Need for blood and platelet transfusions – almost all patients
•Nausea, vomiting, mouth ulcers and diarrhoea – common
•Hair loss – common and temporary
•Serious fungal infection – about 5–15%
•Bleeding due to low platelets – uncommon if platelets are supported
•Heart damage from anthracyclines – uncommon at standard doses
•Failure to reach remission – about 20–40%, needing a second induction

💰 Cost of AML Induction Chemotherapy in India

The cost of AML induction chemotherapy in India starts from about USD 15,000. This covers about 4 weeks in hospital in a twin-sharing room, standard 7+3 chemotherapy drugs, routine blood tests, standard transfusions and supportive medicines. Targeted drugs, ICU care, expensive antifungals and extra transfusions add to the cost.

Option / Hospital tier	Approx. cost (USD)	Hospital stay	Notes
AML induction (7+3) – this package (twin sharing)	15,000	4 weeks	Standard drugs and supportive care
Induction in single / HEPA room at premium centre	18,000 – 25,000	4–5 weeks	Private isolation room
Induction with targeted drug (midostaurin / gemtuzumab)	22,000 – 35,000	4–5 weeks	Depends on drug and duration
Consolidation (high-dose cytarabine) per cycle	4,000 – 7,000	5–10 days	Usually 3–4 cycles
Allogeneic bone marrow transplant	25,000 – 40,000	4–6 weeks	If advised after remission

⚠️ Final cost depends on the AML type, genetic tests, drugs used, infections, number of transfusions, ICU need and the hospital chosen. Quotes are confirmed after the haemato-oncologist examines the patient in India.

AML Induction Chemotherapy cost comparison India USA UK Turkey

📋 What the Package Includes

✅ Included

✔7+3 induction chemotherapy drugs
✔About 4 weeks in twin-sharing room
✔Haemato-oncologist fees
✔Routine blood tests
✔Standard blood & platelet transfusions
✔Routine antibiotics & supportive medicines
✔Nursing care & meals

❌ Not Included

✖Bone marrow, genetic & molecular tests
✖Targeted drugs (midostaurin, gemtuzumab, etc.)
✖Expensive antifungals beyond package
✖ICU stay
✖Extra days beyond 4 weeks
✖Consolidation & bone marrow transplant
✖Hotel, food & air tickets

✈️ Your Medical Travel Process with Satyug Healthcare

Medical travel journey to India for AML Induction Chemotherapy

Step	Details
1. Send reports	Complete blood count with smear, bone marrow report, flow cytometry, cytogenetic and molecular results (FLT3, NPM1, etc.) if done, echo, kidney and liver tests, and a summary of any treatment already given.
2. Free opinion & quotes	Within 48-72 hours you receive opinions and cost estimates from 3-5 leading hospitals to compare.
3. Choose hospital & doctor	We help you compare doctors, success rates, room options and total budget.
4. Medical visa	The hospital issues a Visa Invitation Letter (VIL) to the Indian Embassy. The patient and up to 2 attendants apply for an e-Medical / Medical Attendant visa.
5. Travel planning	Flight guidance, wheelchair assistance, airport pick-up, hotel or guest house near the hospital.
6. Treatment in India	Your coordinator and interpreter stay with you for admission, treatment, discharge and billing.
7. Return & follow-up	Fit-to-fly letter, medicines, and online follow-up with your doctor after you return home.

🎒 Travel Checklist

📌Valid passport (6+ months) for the patient and attendants, plus 10 passport-size photos each
📌Medical visa / e-visa and the hospital’s Visa Invitation Letter
📌All blood and bone marrow reports, flow cytometry and genetic reports, echo and discharge summaries with prescriptions
📌Yellow fever vaccination certificate (mandatory for travellers from African countries)
📌Polio vaccination certificate where applicable
📌Declare cash above USD 5,000 at the airport; hospitals accept wire transfer and cards
📌Foreigners staying longer than permitted must register with the FRRO — our team assists

⭐ Why Choose Satyug Healthcare?

🏥

Top Accredited Hospitals

Leading haemato-oncology and bone marrow transplant centres include Medanta – The Medicity (Gurugram), Max Super Speciality Hospital Saket (Delhi), Fortis Memorial Research Institute (Gurugram), BLK-Max (Delhi), Artemis Hospital, Apollo Hospitals (Chennai and Delhi), Narayana Health (Bengaluru) and Tata Memorial-linked centres.

👨‍⚕️

Senior Specialists

Treatment is led by haemato-oncologists who manage acute leukaemia and bone marrow transplant daily, with infection specialists and 24-hour transfusion support.

💵

Transparent Pricing

Multiple written quotes to compare — no hidden charges, no extra fee for our service.

🤝

End-to-End Support

Visa, airport pick-up, accommodation, interpreter and 24/7 coordinator.

❓ Frequently Asked Questions

➤ What is the cost of AML induction chemotherapy in India?

It starts from about USD 15,000 for about 4 weeks in hospital with standard 7+3 chemotherapy in a twin-sharing room. Targeted drugs or a private isolation room increase the cost.

➤ How long will I stay in India?

Plan for at least 5–6 weeks for induction. If consolidation or a bone marrow transplant is done in India, the total stay may be 4–6 months.

➤ What is the chance of remission?

About 60–80% of adults under 60 and about 40–60% of fitter older adults reach complete remission after induction. Children respond even better.

➤ Is induction enough to cure AML?

No. Induction brings remission, but consolidation chemotherapy and, for many, a bone marrow transplant are needed to stop the leukaemia from returning.

➤ Why is such a long hospital stay needed?

Chemotherapy lowers blood counts for 2–3 weeks. During this time patients need protection from infection, transfusions and quick treatment of fever.

➤ Will I lose my hair?

Usually yes, about 2–3 weeks after starting. Hair grows back after treatment ends.

➤ What are the main risks?

Infections, bleeding, mouth ulcers and nausea are common. Serious infections can be life-threatening, which is why care is given in specialised units.

➤ Can older patients be treated?

Yes. Fit older adults may receive intensive induction, while others may receive gentler azacitidine or decitabine with venetoclax.

➤ Do I need a bone marrow transplant?

It depends on the genetic risk. Intermediate and high-risk AML usually need a transplant in first remission. Siblings should get HLA testing early.

➤ Can a family member donate blood?

Yes. Family members with compatible blood groups can donate blood and platelets, which helps a lot during treatment.

💬 Get a Free Opinion & Cost Estimate

Send your medical reports today and receive opinions from India’s top specialists within 48-72 hours.

📞 +91-8860606766 | +91-9910655125 | ✉️ query@satyughealthcare.com

Medical disclaimer: This page is for general information and does not replace a consultation with a qualified specialist. Treatment plans and costs are confirmed only after the patient is examined. Sources: NCCN Clinical Practice Guidelines: Acute Myeloid Leukemia (2024); European LeukemiaNet (ELN) 2022 recommendations; NCBI StatPearls: Acute Myeloid Leukemia; RATIFY trial (Stone et al., NEJM 2017); American Cancer Society: AML treatment; Mayo Clinic: Acute myelogenous leukemia. Infographics: Satyug Healthcare.